Ligand Pharmaceuticals, Inc (LGND) Covered Calls

Ligand Pharmaceuticals, Inc covered calls Ligand Pharmaceuticals, Inc. focuses on drug discovery & early-stage development of pharmaceuticals that address critical unmet medical needs or that are more effective or safer than existing therapies, more convenient to administer & are cost effective.

You can sell covered calls on Ligand Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LGND (prices last updated Mon 11:15 AM ET):

Ligand Pharmaceuticals, Inc (LGND) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
124.86 +5.84 124.77 124.98 247K - 2.4B
Covered Calls For Ligand Pharmaceuticals, Inc (LGND)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Apr 18 125 6.10 118.88 5.1% 58.2%
May 17 125 9.80 115.18 8.5% 50.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them to a lean corporate cost structure. Its products address the unmet medical needs of patients for a broad spectrum of diseases, including hepatitis, muscle wasting, alzheimer's disease, dyslipidemia, diabetes, anemia, asthma, rheumatoid arthritis and osteoporosis. The company operates its business through two segments: CyDex and Ligand. The CyDex segment engages in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc. Ligand Pharmaceuticals was founded by Ronald M. Evans in 1987 and is headquartered in La Jolla, CA.